MTACU
MedTech Acquisition Corporation · NASDAQ
MedTech Acquisition Corporation (MTACU) is a Business Services company listed on NASDAQ. There were no new wire items for MTACU in the last 30 days. The most recent was published Dec 8, 2022.
Latest news
7 items- PRMedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of StockholdersThe Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (NASDAQ:MTAC) ("MedTech" or the "Company") today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the "Special Meeting") in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022. The Special Meeting is being adjourned in order to solicit more votes toward the approval to amend the Company's amended and restated certificate of incorporation
- PRPeregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC dealOR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ:MTAC), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, including surgical robots. Memic is an Israeli based medical device company, founded and grown in Peregrine's incubator, that has developed the Hominis®, a robotic platform for surgical procedures. Following the completion of the business combination transaction – expected in the fourth quarter of 2021 – the combined company will operate under the Memic name with an es
- 13D/GSEC Form SC 13G filedSC 13G - MedTech Acquisition Corp (0001826667) (Subject)
- SECSEC Form 8-K filed8-K - MedTech Acquisition Corp (0001826667) (Filer)
- PRMedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and warrants included in the units. The shares of Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market (“Nasdaq”) under the symbols “MTAC” and “MTACW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on Nasdaq under the symbo
- 13D/GSEC Form SC 13G filedSC 13G - MedTech Acquisition Corp (0001826667) (Subject)
- SECSEC Form SC 13G filedSC 13G - MedTech Acquisition Corp (0001826667) (Subject)
MTACU FAQ
7 questionsWhat does MedTech Acquisition Corporation do?
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.What is the latest news on MTACU?
Quantisnow has not tracked any new filings, ratings or press releases for MTACU in the last 30 days. The most recent wire item was published on December 8, 2022.Where does MTACU stock trade?
MedTech Acquisition Corporation (MTACU) is listed on NASDAQ.What sector and industry is MTACU in?
MedTech Acquisition Corporation operates in the Finance sector, Business Services industry.When did MedTech Acquisition Corporation go public?
MedTech Acquisition Corporation (MTACU) completed its IPO in 2020.What companies are similar to MTACU?
Notable peers in the same industry include UBER (Uber Technologies Inc.), BABA (Alibaba Group Holding Limited), MA (Mastercard Incorporated), PDD (PDD Holdings Inc.), V (Visa Inc.). Compare MTACU side-by-side with any of them on Quantisnow.How can I track MTACU on Quantisnow?
Quantisnow aggregates MedTech Acquisition Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MTACU to receive live email and push alerts on every new disclosure.